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Abstract
Pavlovian fear conditioning is an associative learning paradigm in which mice learn to associate a neutral conditioned
stimulus with an aversive unconditioned stimulus. In this study, we demonstrate a novel role for the transcriptional
regulator Lmo4 in fear learning. LMO4 is predominantly expressed in pyramidal projection neurons of the basolateral
complex of the amygdala (BLC). Mice heterozygous for a genetrap insertion in the Lmo4 locus (Lmo4gt/+), which express
50% less Lmo4 than their wild type (WT) counterparts display enhanced freezing to both the context and the cue in which
they received the aversive stimulus. Small-hairpin RNA-mediated knockdown of Lmo4 in the BLC, but not the dentate gyrus
region of the hippocampus recapitulated this enhanced conditioning phenotype, suggesting an adult- and brain region-
specific role for Lmo4 in fear learning. Immunohistochemical analyses revealed an increase in the number of c-Fos positive
puncta in the BLC of Lmo4gt/+ mice in comparison to their WT counterparts after fear conditioning. Lastly, we measured
anxiety-like behavior in Lmo4gt/+ mice and in mice with BLC-specific downregulation of Lmo4 using the elevated plus maze,
open field, and light/dark box tests. Global or BLC-specific knockdown of Lmo4 did not significantly affect anxiety-like
behavior. These results suggest a selective role for LMO4 in the BLC in modulating learned but not unlearned fear.
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Introduction
Pavlovian fear conditioning (FC) is a well characterized
behavioral paradigm extensively used to study learning and
memory in rodents [1,2]. In this paradigm, mice learn to associate
a neutral conditioned stimulus (CS) with an aversive uncondi-
tioned stimulus (US), such that exposure to the CS by itself elicits a
species-specific defensive response. Several studies implicate a
central role for the basolateral complex of the amygdala (BLC,
comprised of the lateral, basal, and accessory basal nuclei) in fear
learning [1]. Integration of the CS and US [3] in the BLC triggers
long term potentiation and activity dependent changes in gene
expression which in turn result in changes in synaptic structure
and function that underlie the formation of long term memories
[4,5,6]. De novo gene expression has been shown to play a critical
role in the formation of long term memories in a wide variety of
organisms [7,8]. Transcriptional regulators including cAMP
response element binding protein (CREB) and methyl CPG
binding protein 2 (MeCP2) have been shown to function in the
BLC to regulate fear learning, suggesting that transcriptional
regulation within the BLC may underlie aspects of aversive
conditioning [9,10].
LIM-only (LMO) proteins regulate gene transcription indirectly
by interacting, via their LIM domains, with transcription co-
factors and regulatory DNA–binding proteins [11,12,13]. An
unbiased genetic screen in Drosophila conducted in our laboratory
identified the LIM-only (dLmo) gene as an important regulator of
cocaine sensitivity [14]. Mammalian genomes encode four LMO
genes, LMO1–4. Recent findings from our laboratory implicate
Lmo4 and its transcriptional targets in the nucleus accumbens in
cocaine-induced behavioral plasticity [15,16]. Lmo4 is also highly
expressed in brain structures involved in fear learning including
the BLC, hippocampus, and prefrontal cortex (PFC)
[11,15,17,18]. Lmo4 levels in the brain are dynamically regulated
in a circadian-dependent manner as well as by sleep deprivation
[19,20]. Mammalian homologs of dLMO have been shown to
form large multimeric protein complexes that are hypothesized to
repress transcription [21,22,23]. However, recently it has been
shown that LMO4 can also activate transcription in a calcium
dependent manner [24]. LMO4 could therefore impact synaptic
plasticity by regulating gene transcription in an activity-dependent
manner. These observations, together with the enriched expres-
sion of Lmo4 in the fear circuit led us to hypothesize that Lmo4
might play a role in fear learning.
Results outlined in this study highlight a novel role for the
transcriptional regulator LMO4 in fear learning. LMO4 is highly
expressed in the pyramidal projection neurons of the BLC. Global
or adult- and BLC-specific knockdown of Lmo4 enhanced freezing
to both the context and the cue in a FC paradigm. In addition,
Lmo4gt/+ mice displayed enhanced neuronal activation after fear
conditioning, which may explain the enhanced freezing observed
in these mice. In addition, reduction of Lmo4 levels globally or in
the BLC did not affect unlearned or innate fear, suggesting a
specific role for Lmo4 in the BLC in modulating learned fear.
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Ethic statement
All animal protocols were approved by the Ernest Gallo Clinic
and Research Center (EGCRC) Institutional Animal Care and
Use Committee (approval number 09.11.198).
Subjects
The generation and characterization of mice with a genetrap
insertion in exon 4 of Lmo4 (designated as Lmo4gt) have been
described previously [15]. 8–10 week old male heterozygous
Lmo4gt (Lmo4gt/+) mice that were backcrossed to C57BL6/J mice
for 8–9 generations and their WT littermates were used in this
study. 8–12 week old C57BL6/J mice were used for stereotaxic
surgeries. Mice were group housed until surgery after which they
were individually housed. All animals used in the study were on a
12-hour light/dark cycle and provided with food and water ad lib.
Antibodies
Goat anti-LMO4 antibody and rabbit anti-c-Fos antibody were
from Santa Cruz biotechnology (Santa Cruz, CA). Mouse anti-
CamKII-a antibody was from Upstate (Lake Placid, NY). Mouse
anti-GFP monoclonal antibody (3E6) was purchased from
Invitrogen (Carlsbad, CA). Monoclonal anti-calretinin antibody
was from Millipore (Billerica, MA). Monoclonal anti-parvalbumin
and anti-calbindin antibodies were from Sigma (St. Louis, MO).
Lentiviral shRNA constructs
The design and cloning of small hairpin RNA’s against Lmo4
(designated as shLmo4) as well as control scrambled shRNA
(designated as shScr) that does not target any gene in the mouse
genome have been described [15,25].
Stereotaxic surgery
8–12 week old male C57BL6/J mice were infused bilaterally
with lentivirus as described previously [15,26]. Viral titers were in
the range of 1610
7–10
8 pg/ml. 1 ml of virus was infused into the
BLC using a Hamilton syringe. The coordinates for BLC were A/
P=21.6, M/L=63.1, D/V=24.8 [27]. The coordinates for the
dentate gyrus (DG) sub region of the hippocampus were A/
P=21.9, M/L=62.1, and D/V=22.1. Mice were injected
bilaterally (both BLC and DG) and allowed to recover for 2 weeks
before being subjected to behavioral testing.
Laser capture microdissection (LCM)
Mice were infected with shLmo4 or shScr virus and allowed to
recover for 3 weeks. Mice were then euthanized with CO2 and
their brains were frozen in 250uC isopentane. 30 mm sections
were collected on to membrane slides (Leica microsystems). The
slides were then dehydrated with graded alcohol and xylene.
Infected cells were visualized by GFP and captured using a Leica
laser capture device (Leica microsystems). RNA was isolated from
the collected tissue using the RNeasy kit from Qiagen (Valenica,
CA). Complementary DNA (cDNA, from approximately 300–
400 ng of RNA) was synthesized using reverse transcription
reagents from Applied Biosystems (Foster city, CA). Following
synthesis, cDNA was diluted 1:5 in water. TaqMan qPCR was
performed using standard thermal cycling conditions on an ABI
PRISM 7900 Sequence Detection System (Applied Biosystems).
The sequences of the mouse Lmo4 probe and primers are
published [15]. Mouse Gapdh probe and primers (from Applied
Biosystems) were used as controls.
Immunohistochemistry
Verification of placements. For GFP immunostaining to
verify placements, mice were anesthetized by injecting Euthasol
and perfused transcardially with 0.9% saline before perfusion with
4.0% PFA in PBS for 5 min. Brains were removed, fixed in 4%
PFA overnight at 4uC and transferred to 30% sucrose solution at
4uC where they remained for 1–2 days until they were sectioned.
Brains were mounted using Tissue-Tek OCT (Ted Pella Inc.,
Redding, CA) and 50 mm free-floating sections were cut using a
cryostat (Microm, Thermo Fisher Scientific, Waltham, MA). The
sections were then were pretreated with 3% H2O2 for 10 minutes
followed by 50% ethanol twice for 10 minutes each. Sections were
blocked with 10% normal donkey serum (NDS, Jackson
Immunoresearch, West Grove, PA) for 10 minutes and
incubated with mouse anti-GFP monoclonal antibody diluted
1:1500 in PBS with 0.1% Triton-X-100 for 48 hours. Sections
were washed three times for 5 minutes with PBS and then
incubated with 2% NDS for 10 minutes. Biotin-conjugated
donkey anti-mouse secondary antibody (diluted 1:250; Jackson
Immunoresearch, West Grove, PA, USA) was incubated with
sections for 2–3 hours, followed by ExtrAvidin (1:2500; Sigma) for
1–2 hours. Diaminobenzidine was used for brown color detection
of the GFP immunostaining. Sections were washed with PBS,
mounted on gelatin-coated slides and dried. Slides were stained
with cresyl violet according to standard protocols.
Immunostaining for LMO4, GFP, calbindin, calretinin,
parvalbumin, and c-Fos. For immunofluorescent detection of
LMO4, GFP, calbindin, calretinin, parvalbumin, and c-Fos,
sections were generated and treated as above, except
fluorescently labeled secondary antibodies were used. Goat anti-
LMO4 antibody was diluted 1:500. Mouse anti-GFP was diluted
1:1000. Rabbit anti-c-Fos antibody was diluted to 1:1000. Mouse
anti-calbindin, anti-calretinin, and anti-parvalbumin antibodies
were diluted 1:1000. Secondary antibodies were Alexa fluor-
conjugated donkey anti-goat, donkey anti-mouse, and donkey
anti-rabbit (Invitrogen, Carlsbad, CA), all diluted 1:300. After
staining, sections were mounted on slides with Vectashield
fluorescent mounting medium containing DAPI (Vector
Laboratories, Burlingame, CA, USA). Images were acquired
using Zeiss LSM 510 META laser confocal microscope (Zeiss
MicroImaging, Thornwood, NY) using factory recommended
configurations.
Image J was used to quantify c-Fos positive puncta. Images were
acquired at 106 magnification. For consistency in quantification
across samples, the boundary of the amygdala was set along the
antero-posterior axis from 21.4 to 22.3. The number of Fos-
positive puncta/area was quantified by an observer blind to the
experimental condition and genotype.
LMO4 and CaMKII-a double staining. To determine co-
localization of LMO4 with CaMKII-a, mice were perfused with
4% paraformaldehyde in phosphate buffer; brains were postfixed
for 4 hours in the same fixative, rinsed and then immersed in 30%
sucrose for 48 hours. Frozen 16 mm-thick coronal sections were
cut on a cryostat (Microm, Thermo Fisher Scientific, Waltham,
MA) and collected on adhesive slides (Thermo Fisher Scientific).
Slides with tissues were dried for 30 minutes at 37uC, and
processed for heat-induced epitope retrieval (HIER) using an
unmasking buffer (pH 6.0, H-3300, Vector Labs, Burlingame, CA)
and a pressure chamber with the temperature set at 115uC for
30 seconds (DS2002, Biocare Medical, Concord CA). Slides were
rinsed in PBS and incubated in 0.05% Trypsin (Sigma-Aldrich) in
1% normal donkey serum (NDS, Jackson Immunoresearch, West
Grove, PA) in PBS at 37uC for 20 minutes, rinsed 5 times in PBS,
incubated in 10% NDS for 30 minutes and incubated overnight in
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CaMKII-a (#05-532, 1:500, Upstate, Millipore, Billerica, MA);
and goat polyclonal anti-LMO4 (C-15, 1:200; Santa Cruz
Biotechnology, Santa Cruz, CA) at the room temperature. Next
day slides were rinsed in PBS incubated in 2% NDS for
10 minutes and incubated in the mixture of secondary
antibodies: Alexa Fluor 488-labeled donkey anti-mouse, and
Alexa Fluor 594-labeled donkey anti-goat (1:250, Invitrogen,
Carlsbad, CA) for 4 hours.
C-Fos and CaMKII-a double staining. Because the above
HIER pre-treatment had a suppressing effect on the c-Fos antigen
but was necessary for CaMKII-astaining, we performed a
sequential immunostaining procedure in which c-Fos staining
was done prior to HIER and CaMKII-a staining. The anti-c-Fos
primary rabbit polyclonal antibody (1:800) was applied first using a
conventional immunostaining protocol (with no HIER, and no
trypsin pre-treatments) overnight, followed by rinses and 4-hour
incubation in secondary Alexa Fluor 594-labeled donkey anti-
rabbit. Sections were then rinsed in PBS, incubated in 4% in PFA
for 45 minutes (to retain the c-Fos immunostaining) followed by 3
rinses in PBS for 5 minutes each after which HIER was applied.
The trypsin step was omitted to avoid loss of c-Fos
immunostaining. After blocking in 10% NDS the tissue was
incubated in anti-CaMKII-a primary antibody overnight and
followed by secondary Alexa Fluor 488-labeled donkey anti-
mouse. To ensure that PFA-HIER treatment did not cause loss of
c-Fos staining, we compared c-Fos staining before and after this
step. Control experiment also included omitting primary
antibodies in which no specific staining was observed. Sections
were briefly air dried and coverslipped using Vectashield
mounting media (Vector Labs). Images were acquired using
Zeiss LSM 510 META laser confocal microscope (Zeiss
MicroImaging, Thornwood, NY) using 406/NA1.3 oil
immersion lens and factory recommended configurations. Short
stacks of confocal images from BLA were collected within 5–
7 mm’s from the tissue surface, where the antibody penetration was
optimal.
Behavioral analyses
Before testing all mice were habituated to the behavioral room
for 1 hour. All behavioral testing was done at the same time of
day.
Fear conditioning. Mice were subjected to FC using three
tone-shock pairings. FC was performed in ‘‘Freeze Monitor’’
chambers (San Diego Instruments, San Diego, CA) that were
equipped with infrared photobeams, which allowed for high
resolution scoring of freezing behavior. The amount of time mice
spent freezing was calculated from the beam-break data [28]. Mice
were placed in the FC chambers and allowed to habituate for
2 minutes, following which they were presented with an 80-decibel
tone for 30 second duration. The tone co-terminated with a
0.5 mA foot shock, which lasted for 2 seconds. Mice were
subjected to two more CS/US presentations with an inter-trial
interval (ITI) of 60 seconds. Beam breaks were recorded during
the entire conditioning session to determine baseline (first two
minutes) as well as post shock freezing. Mice were removed from
the chambers 30 seconds after the delivery of the last foot shock
and returned to their home cages. The chambers were cleaned
between subjects using 70% ethanol. Contextual fear conditioning
was analyzed 24 hours later by placing mice in the FC chambers
for 3 minutes. Freezing during the entire 3 minute duration was
recorded. 2 hours after contextual FC, freezing to the cue was
assessed in an altered context. The context was altered by covering
the walls of the chamber with paper and changing the texture of
the floor. Additionally, the chambers were cleaned with a
eucalyptus-scented cleaner. Mice were placed back in the
chamber and subjected to 3 tone presentations, each of 30-
second duration with varying ITIs. Freezing to the tone was
recorded. For the ‘‘no conditioning’’ control group mice were
placed in the FC chambers for 5 minutes but not subject to tone-
shock pairings.
Elevated plus Maze. The elevated plus maze consisted of
two open and two closed arms perpendicular to each other. The
maze was elevated approximately 40 cm above the ground. The
open arms measured 70 cm long69 cm wide. The closed arms
were identical to the open arms but were enclosed by a 12 cm high
wall. Mice were placed in the center of the maze facing the open
arms and allowed to explore the maze for 5 minutes. The entire
session was recorded using a video camera and the results were
scored manually by an observer blind to the genotype and
experimental conditions. Parameters measured included number
of open arm entries as well as the amount of time spent in open
arms.
Light/Dark Box. The light/dark box apparatus consisted of
an automated activity monitor chamber that was fitted with a
light/dark box insert (ENV-510, Med Associates, St. Albans, VT).
The light and dark compartments each measured
24 cm628 cm625 cm and were enclosed in a sound attenuating
chamber. The light side of the compartment was brightly lit
(100 Lux). Mice were placed in the lit chamber facing the dark
compartment and their activity was recorded for 5 minutes using a
photobeam-based tracking system. Time spent in each of the
compartments was recorded.
Open field test. Mice were placed in Plexiglas locomotor
activity chambers (43 cm643 cm; MED Associates, St. Albans,
VT), located in sound-attenuating cubicles equipped with a 2.8 W
house light and exhaust fans that mask external noise. The
chambers contain two sets of 16 pulse-modulated infrared
photobeams on opposite walls to record x, y ambulatory
movements, and are computer interfaced for data sampling at
100 ms resolution. Mice were placed in the chambers for
5 minutes and the amount of time they spent at the center and
the periphery of the chamber was recorded. The same set of mice
was used in all three behavioral paradigms measuring anxiety. The
elevated plus maze test was performed first followed by the light/
dark box and the open field test. Mice were allowed 1 week to
recover between tests.
Statistical analysis
Two- way repeated measures (RM) analysis of variance
(ANOVA) with genotype6test (baseline, context, and cue)
followed by Neumann-Keul’s posthoc analyses was used to
analyze fear conditioning data. Two-way ANOVA (genotype6ses-
sion) followed by Bonferroni posthoc test was used for analysis of
immunohistochemistry results. Student’s t-test was used to analyze
results from behavioral paradigms used to measure anxiety-like
behavior and to analyze quantitative PCR data. All statistical
analyses were performed using Sigmastat and Graph pad prism
software.
Results
LMO4 is highly expressed in the BLC (Figure 1). To determine
the cell types in which LMO4 is expressed, we first examined co-
localization of LMO4 protein with the CamKII-a subunit, a
marker for pyramidal projection neurons in the BLC [29]. Our
results indicate that LMO4 expression in the BLC overlaps
extensively with that of CaMKII-a, with LMO4 expression
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(Figure 1). We also examined co-localization of LMO4 with
markers for three of the major interneuron populations in the
BLC, namely parvalbumin, calbindin, and calretinin. LMO4
expression did not co-localize with any of these interneuron
markers (Supplementary Figure S1). Taken together, these results
suggest that LMO4 is predominantly expressed in pyramidal
projection neurons of the BLC.
Since the function of pyramidal projection neurons is critically
involved in FC [5], we analyzed this behavior in heterozygous
Lmo4gt/+ mice which express 50% less Lmo4 than their WT
counterparts [15]. Lmo4gt/+ mice and their WT littermates were
subjected to FC using three tone/footshock pairings. Two-way
RM ANOVA indicated a significant main effect of genotype [F(1,
60)=10.726, p,0.005], test [F(2, 60)=158.404, p,0.001] and
genotype6test interaction [F(2, 60)=5.985, p,0.005]. Neuman-
Keul’s post-hoc test revealed that Lmo4gt/+ mice freeze signifi-
cantly more to both the context (p,0.001) and the cue (p=0.001)
(Figure 2A) associated with the footshock. No differences were
observed in postshock freezing (WT=38.564.09 seconds, Lmo4gt/
+=46.4465.4 seconds, p=0.25, Student’s t-test) between the
genotypes. We also compared footshock sensitivity of WT and
Lmo4gt/+ mice. No genotypic differences were found in the current
amplitude required to elicit flinching, jumping, and vocalizing
responses (Figure 2B). These results suggest that the differences in
freezing observed between the two genotypes are not due to
altered perception of the US.
To determine if there is an adult- and brain-region specific role
for Lmo4 in FC, short-hairpin RNAs (shRNA) were used to down-
regulate Lmo4 expression in specific brain regions. ShRNAs
directed against a discrete region of Lmo4 were generated and
cloned into a GFP-expressing lentiviral vector as described [15]. A
virus expressing scrambled shRNA (shScr) that does not target any
gene in the mouse genome was used as a negative control. We first
targeted the BLC because of the high levels of LMO4 expression
in the BLC and the critical role it plays in fear learning.
Quantitative PCR performed using RNA extracted from laser
captured tissue from shLmo4- and shScr-infected mice revealed
significant (46%) knockdown of Lmo4 expression in the BLC of
mice injected with shLmo4 (p,0.05, student’s t-test) in compar-
ison to shScr infected mice (Figure 3A). We also examined LMO4
expression in shLmo4 and shScr-infected mice. While we observed
robust expression of LMO4 in GFP-positive (infected) neurons
from shScr infected mice (arrows, left panel Figure 3B), we did not
observe LMO4 expression in GFP-positive neurons in shLmo4-
injected mice (arrows, right panel, Figure 3B). Behavioral analyses
indicated that knockdown (bilateral) of Lmo4 in the BLC
recapitulated the phenotype observed in Lmo4gt/+ mice, and
results in enhanced freezing to both the context and the cue
(Figure 3C). Two-way RM ANOVA revealed a significant main
effect of shRNA [F(1, 40)=0.66, p,0.01], test [F(2, 40)=70.35,
p,0.001], and shRNA6test interaction [F(2, 40)=3.984,
p,0.026]. Further, Neumann-Keuls post hoc analysis indicated
that mice injected with shLmo4 froze significantly more to both
the context (p,0.001) and the cue (p,0.05) in comparison to mice
injected with shScr. Differences were not observed in post
shock freezing between shScr and shLmo4 injected mice
(shLmo4=30.765.77 seconds, shScr=24.563.4 seconds, p=0.35,
student’s t-test).
The hippocampus is critically involved in contextual fear
learning and Lmo4 is expressed in the CA1, CA3, and DG regions
(Figure 4A) of the hippocampus [15]. Several reports suggest an
important role for the DG in contextual FC [30,31]. Hence, we
decided to examine the effects of Lmo4 downregulation in the DG
Figure 1. Co-localization of LMO4 and CaMKII- a in the BLC. Top panels: Dual-channel immunofluorescence images show high levels of
expression for both LMO4 (A) and CaMKII-a (A9) in the BLC. Scale bar: 200 mm. Bottom panels: strong co-localization of both markers is evident in
numerous BLC neurons (arrows, B, B9, and B0), with the LMO4-postive nuclei and CaMKII-a-positive perikarya. Scale bar: 50 mm.
doi:10.1371/journal.pone.0034559.g001
Lmo4 and Fear Learning
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34559on both contextual and cued FC. Knockdown of Lmo4 in the DG
did not affect freezing to either the context or the cue (Figure 4B).
Two-way RM ANOVA revealed a main effect of test [F(2,
18)=27.23, p,0.001], but no effect of shRNA [F(1,18)=0.0398,
p.0.05] or test6shRNA interaction [F(2, 18)=0.2, p.0.05].
Immunohistochemical analyses conducted after behavioral studies
revealed GFP staining in granule cells throughout the DG as well
as in the mossy fiber projections to the CA3 (Figure 4C).
Integration of the CS and US in the BLC after FC initiates a
cascade of signaling events that culminate with the expression of
immediate-early genes such as c-Fos [4]. To determine whether
downregulation of Lmo4 in pyramidal neurons of the BLC alters
neuronal activation, we examined c-Fos activation in the BLC of
WT and Lmo4gt/+ mice 2 hours after subjecting mice to fear
conditioning. Lmo4gt/+ mice displayed significantly enhanced c-
Fos immunoreactivity in comparison to their WT controls
(Figure 5A and B). Two way ANOVA indicated a significant
main effect of test [F (1, 66)=166.69; p,0.0001], and genoty-
pe6test interaction [F (1, 66)=5.30; p=0.025]. Bonferroni post
hoc test indicated that the number of c-Fos positive puncta was
significantly higher in Lmo4gt/+ mice than in WT littermates
(p,0.01) following conditioning. No differences were observed in
number of c-Fos positive puncta in control WT and Lmo4gt/+ mice
that were exposed to the chambers but not subjected to CS/US
pairings (p.0.05). These results suggest that reducing Lmo4 levels
in the pyramidal projection neurons leads to enhanced neuronal
activation during FC and may underlie the increased freezing
response observed in these mice (Figure 5A and B). To determine
whether reducing Lmo4 levels alters the recruitment of pyramidal
and/or local circuit neurons in fear memory formation, we
examined co-localization of c-Fos with CaMKII-a after fear
conditioning in WT and Lmo4gt/+ mice (Supplementary Figure
S2). We examined 140–160 c-Fos positive cells/genotype from
WT and Lmo4gt/+ mice (n=2 mice/genotype) and found that
approximately 90% of c-Fos positive cells also stained for
CaMKII-a in both genotypes (arrows Supplementary Figure
S2A, top and bottom panels). Approximately 10% of c-Fos positive
cells in both genotypes did not stain for CaMKII-a and are likely
local interneurons (arrow, Supplementary Figure S2B). These
results suggest that pyramidal projection neurons are predomi-
nantly activated in the BLC by fear learning and that reduction in
Lmo4 expression does not change the balance between excitatory
and inhibitory cells in the BLC FC circuit.
The BLC is also important in modulation of unlearned fear or
anxiety [32,33]. To determine whether Lmo4 has a role in learned
as well as unlearned (innate) fear, we compared anxiety-like
behavior in WT and Lmo4gt/+ mice as well as mice in which Lmo4
levels were down-regulated in the BLC using shRNA. We
subjected mice to behavioral paradigms designed to measure
anxiety-like behavior: the elevated plus maze, the open field test,
and the light/dark box test. Analysis in the elevated plus maze
revealed no differences in the number of open (p=0.84, Student’s
t-test) and closed arm (p=0.52) entries made by WT and Lmo4gt/+
mice. Significant differences were also not observed in % open
arm entries (p=0.93) or in % time spent in open arms (p=0.71) in
shLmo4 and shScr injected mice (Table 1). We next subjected
mice to the light/dark box test (Table 1). No differences were
observed in the % time spent in the lit compartment between WT
and Lmo4gt/+ mice (p=0.6) or ShLmo4 and shScr injected mice
(p=0.97). We next examined anxiety-like behavior in an open
field test (Table 1). No differences were observed in the % time
spent in the center of the open field between WT and Lmo4gt/+
mice (p=0.1) or in the total distance traveled (p=0.07).
Differences were also not observed in the amount of time spent
in the center of the open field between shLmo4 and shScr injected
mice (p=0.764) as well as in total distance traveled (p=0.44).
Taken together, these results suggest that Lmo4 functions in the
BLC to specifically affect learned but not innate fear or anxiety.
Discussion
Results outlined in this study demonstrate a novel role for the
transcriptional regulator Lmo4 in the BLC in fear learning. LMO4
is predominantly expressed in pyramidal projection neurons of the
BLC whose function is critical for fear learning. Reducing Lmo4
levels either globally through out development or in an adult- and
brain region-specific manner in the BLC results in enhanced
freezing to both the context and the cue in a FC paradigm.
Furthermore, Lmo4gt/+ mice displayed enhanced c-Fos activation
in the BLC following fear learning suggesting that increased
neuronal activation following CS/US integration may underlie the
increased freezing response observed in these mice. Anxiety-like
behavior was unaffected by global or brain-region specific
Figure 2. Lmo4gt/+ mice display enhanced freezing to the
context and the cue. Lmo4gt/+ mice were subjected to FC using
three tone shock pairings. Time spent freezing to the context and the
cue was determined. A) Lmo4gt/+ mice froze significantly more to both
the context and the cue. Genotypic differences in baseline freezing
were not observed. B) Footshock sensitivity was examined in WT and
Lmo4gt/+ mice. No significant differences were observed in current
intensity required to elicit flinching, jumping, and vocalizing response
between the two genotypes. Data are presented as mean 6 SEM.
*, p,0.05. n=16/group for panel A, n=7/group for panel B.
doi:10.1371/journal.pone.0034559.g002
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34559Figure 3. Knockdown of Lmo4 in the BLC leads to enhanced freezing to the context and the cue. A) Quantification of knockdown of Lmo4
(RNA) expression in the BLC. Lmo4 levels were quantified in laser captured tissue from shLmo4 and shScr infected mice by QPCR. Lmo4 levels were
significantly decreased (by 46%) in shLmo4 infected cells compared to the shScr control. *, p,0.05, n=6 (shLmo4) and 10 (shscr). B)
Immunohistochemical analyses revealed a robust decrease in LMO4 expression in GFP positive/infected cells (arrows point to infected neurons, right
panel) from shLmo4-injected mice but not from shScr-injected mice (arrows point to infected neurons, left panel). Co-localization of LMO4 and GFP
observed as yellow overlap in nuclei can be observed in shScr- but not shLmo4-infected neurons. Scale bar: 50 mm B) Knockdown of Lmo4 expression
in the BLC results in increased freezing to both the context and the cue. No differences in baseline freezing were observed between the two different
shRNA’s. Data are represented as mean 6 SEM. n=10–12/group. C) Left panel: Representative image of viral infection is shown. Viral infection was
visualized by staining for GFP. Right panel: Serial reconstruction of injection sites is shown.
doi:10.1371/journal.pone.0034559.g003
Figure 4. Knockdown of Lmo4 in the DG does not affect freezing to the context or the cue. Freezing responses were measured after
knockdown of Lmo4 expression in the DG. A) LMO4 (red) is highly expressed in the DG, and CA1 and CA3 sub regions of the hippocampus. Scale bar:
200 mm. B) Knockdown of Lmo4 in the DG sub-region of the hippocampus does not significantly affect freezing behavior to either the context or the
cue. Baseline freezing was also not affected. Mean 6 SEM are depicted. N=6/group. C) Right Panel: Image depicting area of infection in the DG. Scale
bar: 200 mm. Left panels: Higher resolution image of the boxed areas reveal GFP staining in the granule cells as well as in the mossy fiber projections
to the CA3 region.
doi:10.1371/journal.pone.0034559.g004
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role for Lmo4 in regulating learned fear but not unlearned fear.
Contextual FC is conventionally thought to be dependent on
both the hippocampus and the BLC, whereas cued FC is believed
to be dependent on the BLC [34,35]. Lmo4gt/+ mice freeze
significantly more to both the context and the cue. Since Lmo4 is
expressed in both the hippocampus and the BLC, we sought to
determine the brain region within which Lmo4 might be
functioning to modulate fear learning. shRNA-mediated down-
regulation of Lmo4 in the BLC recapitulated the phenotype
observed in Lmo4gt/+ mice whereas knockdown of Lmo4 in the
DG, a brain region known to be important for modulation of
contextual fear learning [30,31], had no effect on either contextual
or cued FC. These results provide evidence for brain region
specificity to the effects of Lmo4 on fear learning. Lmo4 is also
highly expressed in the prefrontal cortex (PFC), and the CA1, and
CA3 regions of the hippocampus, which are also implicated in
certain aspects of fear learning [36,37]. Our results suggest that
knockdown of Lmo4 in the BLC but not the DG is sufficient to
recapitulate the behavioral phenotype observed in Lmo4gt/+ mice.
However, it is possible that Lmo4 expression in other brain regions
such as the PFC could also impact fear learning.
A role for transcriptional regulators in fear learning has been
demonstrated previously. Knockdown of the transcriptional
repressor methyl-CpG binding protein 2 (MeCP2) in the BLC
has been shown to decrease freezing to the cue and results in a
trend towards decreased freezing to the context [10]. Mice over
expressing histone deacetylase 2 (HDAC2), which can repress
transcription through histone deactivation, display reduced
freezing to both the context and the cue [38]. Localized over
expression of the transcription factor CREB in the BLC has been
shown to enhance fear memory [9]. These results highlight the
importance of gene expression-dependent changes in synaptic
structure and function in the formation of fear memories. Further,
LMO4 has been shown to associate with HDAC2 (in breast cancer
cell lines, [21,39]) and with CREB [16]. Hence, it is possible that
LMO4 mediates some of its effects on fear learning through its
interactions with other known regulators of learning and memory.
Studies have implicated a role for BLC in modulating unlearned
fear/anxiety as well [32,33]. Enhancement of glutamatergic
neurotransmission in the BLC is thought to increase anxiety
[33]. Since LMO4 is predominantly expressed in glutamatergic
projection neurons of the BLC, we sought to determine whether
reduction in Lmo4 levels had an impact on anxiety-like behavior.
We subjected Lmo4gt/+ mice and their WT littermates as well as
mice injected with shLmo4 and shScr to a battery of behavioral
paradigms that measure anxiety-like behavior namely, the elevated
Figure 5. Lmo4gt/+ mice display increased neuronal activation
after FC. Neuronal activation in the BLC was assessed 2 hours after FC
in both WT and Lmo4gt/+ mice by measuring c-Fos positive puncta in
the BLC. Control mice were exposed to the FC chambers but not
subjected to tone/shock pairings. A) Genotypic differences in c-Fos
staining were not observed in the BLC under control conditions. After
FC, Lmo4gt/+ mice displayed significantly more c-Fos positive puncta
than their WT counterparts. Scale bar: 200 mm. B) Quantification of
results in panel A. Data are presented as mean 6 SEM. *, p,0.05. n=3–
5/group.
doi:10.1371/journal.pone.0034559.g005
Table 1. Reduction in Lmo4 levels does not affect anxiety-like behavior.
Behavior Parameter measured WT Lmo4gt/+ shLmo4 shScr
Elevated Plus Maze % Open Arm Entries 41.1463.03 40.4162.23 36.5463.5 37.6663.76
% Time in Open Arms 19.4263.81 22.7263.43
29.8463.98 27.6264.87
Light/Dark Box % Time in Lit Compartment 35.4461.68 38.6366.62 29.764.18 29.563.6
Open Field % Time Spent in Center 16.7761.85 12.7461.44 9.9261.47 10.5661.48
Distance Traveled (cm) 1028.2661.81 817.91690.89 1118.39686.65 1031.17668.48
The effects of global (Lmo4gt/+) or adult-and brain region-specific knockdown of Lmo4 in the BLC on anxiety-like behavior was examined. Mice were subjected to the
elevated plus maze, light/dark box, or the open field test. Mean values 6 SEM are depicted. N=11–12 (WT) and 9–11 (Lmo4gt/+) mice and n=9–10 for shLmo4 and 10
for ShScr injected mice.
doi:10.1371/journal.pone.0034559.t001
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found no differences in anxiety-like behavior between WT and
Lmo4gt/+ mice. Several studies suggest a role for brain regions
such as the PFC and hippocampus in anxiety-like behavior [40].
Our results with Lmo4gt/+ mice suggest that reductions in Lmo4
levels in several brain regions implicated in unlearned fear such as
the hippocampus, PFC, and amygdala do not affect anxiety-like
behavior. ShRNA-mediated knockdown of Lmo4 in the BLC in
adults also did not alter anxiety-like behavior. Taken together,
these results argue against a role for Lmo4 in anxiety like-behavior.
However, an important caveat to these experiments is that the
same set of mice was used in all three behavioral paradigms used
to measure anxiety-like behavior. One of the advantages in
subjecting the same mice to a battery of behavioral paradigms is
the ability to fully explore the range of the phenotype [41,42].
However, there are also potential confounds. Chief among them
being that prior exposure to an anxiety-related test could influence
behavior in subsequent tests [41,42]. To minimize the effects of
repeated testing, we allowed for the mice to recover for 1 week
between tests. It is however possible that knockdown of Lmo4
globally or in the BLC may lead to very subtle effects on anxiety-
like behavior which we were unable to detect due to repeated
testing. The lack of an effect of Lmo4 downregulation in the BLC
on unlearned fear is in contrast to its effects on learned fear. This
not only argues for Lmo4 functioning in specific pathways within
the BLC but also suggests that knockdown of Lmo4 levels does not
result in a general disruption of BLC function.
Integration of CS and US in the lateral amygdala is thought to
lead to long term potentiation and subsequent activation of
signaling events leading to protein synthesis-dependent changes in
synaptic structure and function [43,44]. Indeed, fear memory has
been shown to be sensitive to disruption by protein synthesis
inhibitors administered immediately after training [45,46]. Hence,
we examined neuronal activation by quantifying c-Fos positive
puncta in Lmo4gt/+ mice and their WT littermates after FC. Our
results indicate increased neuronal activation in the BLC of
Lmo4gt/+ mice after FC. This increased neuronal activation,
especially in pyramidal projection neurons, may lead to enhanced
consolidation of fear memories thereby resulting in the excessive
freezing phenotype observed in Lmo4gt/+ mice. We also found that
pyramidal projection neurons, which are the primary loci for
integration of CS and US in the BLC, are predominantly activated
by fear learning in both WT and Lmo4gt/+ mice. Furthermore, the
ratio of pyramidal projection neurons to local interneurons that
are activated by fear learning was unchanged in Lmo4gt/+ mice in
comparison to WT mice. Hence, it is likely that the increase in c-
Fos positive puncta observed in Lmo4gt/+ mice after fear
conditioning results from activation of both pyramidal projection
neurons and local interneurons, thereby leaving the ratio of
activated cell types relatively unchanged. We did not observe any
genotypic differences in the number of c-Fos positive puncta under
control conditions suggesting that the BLA in Lmo4gt/+ mice was
not intrinsically more excitable than that of WT mice. In
summary, our results suggest that reducing Lmo4 levels in the
BLC increases the number of neurons that are activated by fear
learning. Reducing Lmo4 levels may lower the threshold for
neuronal activation by altering the expression of ion channels and
consequently membrane conductance. Future experiments that
compare the electrophysiological characteristics of principal
neurons in the BLC of WT and Lmo4gt/+ mice should provide
insight into the underlying mechanisms. Lmo4 levels are reduced in
all pyramidal neurons in the BLC of Lmo4gt/+ mice; yet, only a
subset of these neurons are activated by coincident CS-US input.
We hypothesize that the transcriptional targets/binding partners
of Lmo4 are different in subsets of pyramidal neurons in the BLC
and this in turn determines which neurons are activated by fear
learning.
Our results implicate a novel and specific role for Lmo4 in the
BLC in fear learning. LMO4 can function as an activity-
dependent modulator of synaptic plasticity [24,47]. Hence, it is
possible that synaptic plasticity caused by CS/US integration may
lead to Lmo4-dependent changes in gene expression. These
changes in gene expression would normally function to dampen
fear memory formation since reduction in Lmo4 levels leads to
enhanced freezing. Based on our results, we hypothesize that an
LMO4-dependent transcriptional network is involved in fear
learning. Future studies will utilize whole-genome approaches to
identify transcriptional targets of LMO4 in the BLC, which may
not only illuminate the mechanism by which LMO4 regulates fear
learning, but also identify potential therapeutic candidates for
treating cognitive impairments associated with a variety of
neurological disorders.
Supporting Information
Figure S1 LMO4 expression is excluded from three of
the major interneuron populations in the BLC. LMO4
expression does not co-localize with markers for three of the major
interneuron populations in the BLC namely calbindin (A),
parvalbumin (B), and calretinin (C), suggesting that LMO4
expression is localized to pyramidal projection neurons of the
BLC (see Figure 1). Scale bar: 50 mm.
(TIF)
Figure S2 C-Fos is predominantly expressed in pyra-
midal projection neurons of the BLC in both WT and
Lmo4gt/+ mice after fear conditioning. A) Majority of the
c-Fos positive cells are also CaMKII-a positive (arrows) in both
WT (top panel) and Lmo4gt/+ mice (bottom panel). B) A
representative image of a c-Fos positive and CaMKII-a negative
cell (arrow) from a WT mouse is shown. Scale bars: 50 mm.
(TIF)
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